Emtricitabine

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Abstract

Emtricitabine (also known as fluorocytidine or FTC) is the negative enantiomer of a thio analog of dideoxycytidine with a fluorine in the 5 position. Emtricitabine is a potent, synthetic nucleoside reverse transcriptase inhibitor with selective activity against HIV-1 and HIV-2 and hepatitis B virus (HBV).

Original languageEnglish
Title of host publicationKucers the Use of Antibiotics
Subtitle of host publicationA Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs
EditorsM. Lindsay Grayson
Place of PublicationBoca Raton FL USA
PublisherCRC Press
Chapter231
Pages3801-3822
Number of pages22
Edition7th
ISBN (Electronic)9781498747967
ISBN (Print)9781498747950
Publication statusPublished - 2 Oct 2017

Cite this

Trevillyan, J., & Wright, E. (2017). Emtricitabine. In M. L. Grayson (Ed.), Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs (7th ed., pp. 3801-3822). CRC Press.